Gene markers could predict which asthmatic kids respond to bronchodilators

Researchers have identified epigenetic markers that may predict how children with moderate-to-severe asthma will respond to bronchodilator medications. The finding could enable doctors to personalize treatment decisions, potentially improving outcomes and reducing trial-and-error prescribing in pediatric asthma care.

Originaltitel: Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma